Introduction
============

Eating disorders (ED) and obesity share some biological and environmental risk factors (Bachar, Gur, Canetti, Berry, & Stein, [@b2]; Bulik, Sullivan, & Kendler, [@b6]; Haines, Kleinman, Rifas-Shiman, Field, & Austin, [@b22]; Root et al., [@b35]), behaviours (Gunnard et al., [@b20]; Roemmich, Lambiase, Lobarinas, & Balantekin, [@b34]) and intermediate neurocognitive phenotypes (Danner, Ouwehand, van Haastert, Hornsveld, & de Ridder, [@b8]; Van den Eynde & Treasure, [@b36]; Volkow, Wang, Fowler, Tomasi, & Baler, [@b38]). A controversial theory postulates that ED and obesity form part of a broad spectrum of eating-related and weight-related disorders (Marcus & Wildes, [@b27]; Volkow & O\'Brien, [@b37]; Wilson, [@b40]). Nevertheless, contradictory findings in the literature do not allow differentiating ED according to weight-related phenotypes.

Obese patients with a comorbid ED \[mainly binge-eating disorder (BED)\] have higher eating (Fassino, Leombruni, Piero, Abbate-Daga, & Giacomo Rovera, [@b14]; Hsu et al., [@b25]), general (Bulik, Sullivan, & Kendler, [@b5]; Fandiño et al., [@b13]; Zeeck, Stelzer, Linster, Joos, & Hartmann, [@b41]) and personality psychopathology (Nasser, Gluck, & Geliebter, [@b30]) and a poorer prognosis (Hsu et al., [@b24]). However, it remains unclear the rate of lifetime obesity across ED diagnostic subtypes and their associated phenotypical features, as well as their stability overtime.

The aims of this study were to examine the prevalence and distribution of lifetime obesity across the range of ED patients to examine temporal changes from 2001 to 2010 and to evaluate the existence of clinical differences between subjects with an ED with and without obesity.

Methods
=======

Participants
------------

The participants were 1383 female ED patients \[261 anorexia nervosa (AN), 551 bulimia nervosa (BN), 448 not otherwise specified ED (EDNOS), and 123 binge-eating disorders (BED)\] with a mean age of 27.0 years (*SD* = 8.25). Patients were consecutively admitted to the ED Unit of our Psychiatry Department, between 2001 and 2010, and diagnosed according to DSM-IV-TR criteria (APA, [@b1]), by means of Structured Clinical Interview for DSM IV Axis I Disorders (First, Gibbon, Spitzer, & Williams, [@b16]). Experienced psychologists and psychiatrists completed the clinical assessment during two structured face-to face interviews. These covered lifetime presence of obesity as well as additional information related to clinical questions such as age of onset, duration, course of the disorder, minimum and maximum body mass index (BMI), presence of family history of obesity and childhood obesity (defined as positive when a subject recalled ever been diagnosed with obesity by a physician in childhood). Patients with lifetime obesity are defined in this work as those having childhood obesity and/or a BMI greater than or equal to 30 kg/m^2^ in adulthood. To determine current obesity, the interviewer directly measured weight and height during this session to calculate BMI.

We obtained written informed consent from all participants, and the Ethics Committee of our hospital approved the study.

Assessment
----------

We developed a comprehensive battery of assessments to quantify ED symptoms, general psychopathology and personality. The battery included the Eating Disorders Inventory-2 (Garner, [@b17]), the Bulimic Investigatory Test Edinburgh (Henderson & Freeman, [@b23]), the Symptom Checklist-Revised-90---Revised (Derogatis, [@b9]) and the Temperament and Character Inventory---Revised (Cloninger, [@b7]). All these questionnaires are validated in Spanish and have been described previously (Derogatis, [@b10]; Garner, [@b18]; Gutierrez et al., [@b21]; Rivas, Bernabé, & Jiménez, [@b33]).

Statistical analysis
--------------------

Statistical analysis was carried out using [spss]{.smallcaps}19 for Windows (IBM Corporation, Armonk, NY). The prevalence of lifetime and childhood obesity was estimated for each diagnostic subtype Clinical and personality differences between ED patients with and without lifetime obesity were analysed using analysis of variance adjusted by age and duration of the ED as covariates.
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Results
=======

Lifetime obesity rate across eating disorders diagnostic subtypes and temporal effects
--------------------------------------------------------------------------------------

Three hundred and ninety eight ED patients had lifetime obesity (28.8%, 95% CI: 26.4 to 31.2). BED individuals had the highest rate (87.8%; 95% CI: 78.6 to 95.7) followed by BN (33.2%, 95% CI: 29.4 to 37.2) and EDNOS (21.2%, 95% CI 17.7; 25.2%) with AN showing the lowest rates (4.6%; 95% CI: 2.64; 7.86).

There was a similar pattern of distribution for family history of obesity (62.8% BED, 33.8% BN, 26.3% EDNOS, 13.3% AN; *p* \< .001) and childhood obesity (28.9% BED, 13% BN, 12.2% EDNOS, 3.6% AN; (*p* \< .001).

In addition, a positive linear trend in the prevalence of lifetime (*p* \< .0001) ([Figure 1](#fig01){ref-type="fig"}) and childhood obesity (*p* \< .0001) and current BMI (*p* \< .0001) was found over the duration of the clinical collection (Figures in supplementary data).

Clinical, psychopathological and personality differences between eating disorders with and without lifetime obesity
-------------------------------------------------------------------------------------------------------------------

Participants with ED and lifetime obesity had higher minimum and maximum BMI, a later age of onset and longer ED duration ([Table 1](#tbl1){ref-type="table"}), higher eating severity scores (*p* \< .001; by means of EDI-2, Bulimic Investigatory Test Edinburgh and bingeing frequency) and greater general psychopathology (*p* \< .005; by means of Symptom Checklist-90---Revised) when compared with ED patients without lifetime obesity. They also showed higher harm avoidance and lower traits on persistence, self-directedness and cooperativeness than ED without this condition.

###### 

Comparison of clinical, psychopathological and personality measures across eating disorders patients with and without lifetime obesity (ED + OB versus ED − OB)

                                ED − OB (*N* = 985)   ED + OB (*N* = 398)   ANOVA                                          
  ----------------------------- --------------------- --------------------- ------- ------ ------------- -------- -------- --------
  BMI: minimum                  17.6                  2.5                   22.0    4.3    **\<.0001**   3.656    3.268    4.044
  BMI: maximum                  23.4                  2.9                   35.0    7.1    **\<.0001**   10.117   9.544    10.690
  Age of onset (years)          18.7                  5.2                   22.0    9.6    **\<.0001**   3.237    2.428    4.046
  Duration of ED (years)        6.4                   5.6                   9.4     7.8    **\<.0001**   3.041    2.289    3.794
  Weekly binges                 3.5                   5.9                   5.6     6.3    **\<.0001**   1.961    1.159    2.763
  Weekly vomits                 4.6                   7.4                   4.1     7.0    .956          0.045    −0.916   1.006
  Weekly laxatives              3.3                   13.0                  3.8     12.3   .956          0.612    −1.078   2.301
  Weekly diuretics              1.1                   4.8                   2.1     6.9    .065          0.801    0.065    1.536
  BITE: symptoms                18.7                  7.8                   23.0    5.6    **\<.001**    3.424    2.220    4.628
  BITE: severity                10.3                  7.4                   12.9    7.3    **\<.001**    2.307    1.097    3.517
  EDI: drive for thinness       12.7                  6.8                   14.2    5.2    .**002**      1.392    0.559    2.225
  EDI: body dissatisfaction     14.7                  8.2                   20.1    6.7    **\<.001**    5.032    4.013    6.051
  EDI: interceptive awareness   10.6                  6.6                   12.4    6.7    **\<.001**    1.871    0.993    2.749
  EDI: bulimia                  5.9                   5.6                   9.14    5.3    **\<.001**    2.989    2.255    3.724
  EDI: interpersonal distrust   5.6                   4.6                   6.2     4.7    .**012**      0.809    0.202    1.415
  EDI: inefficacy               10.3                  7.1                   12.0    7.0    **\<.001**    1.810    0.880    2.740
  EDI: maturity fears           8.0                   5.7                   8.2     5.6    .266          0.457    −0.289   1.203
  EDI: perfectionism            5.6                   4.3                   5.5     4.5    .987          −0.005   −0.576   .567
  EDI: impulsivity              6.5                   5.8                   7.5     6.4    **\<.001**    1.576    0.805    2.348
  EDI: ascetic                  6.6                   4.4                   7.8     4.0    **\<.001**    1.186    0.624    1.748
  EDI: social insecurity        7.5                   5.0                   8.2     4.7    .**005**      0.947    0.298    1.597
  EDI: total score              94.0                  44.3                  111.2   40.3   **\<.001**    17.985   12.32    23.66
  SCL: somatization             1.7                   0.9                   2.0     0.9    **\<.001**    0.324    0.199    .448
  SCL: obsessive--compulsive    1.9                   0.9                   2.1     0.9    .**007**      0.168    0.050    .286
  SCL: interpersonal            1.9                   0.9                   2.2     0.9    **\<.001**    0.280    0.159    .401
  SCL: depressive               2.2                   0.9                   2.4     0.9    .**003**      0.191    0.072    .310
  SCL: anxiety                  1.7                   0.9                   1.9     0.9    .**042**      0.128    0.005    .251
  SCL: hostility                1.4                   1.0                   1.5     1.1    .**008**      0.185    0.051    .319
  SCL: phobic anxiety           1.0                   0.9                   1.2     1.0    .**008**      0.177    0.049    .304
  SCL: paranoid                 1.4                   0.9                   1.6     0.9    .**002**      0.202    0.086    .319
  SCL: psychotic                1.3                   0.8                   1.5     0.8    **\<.001**    0.224    0.120    .327
  SCL: GSI                      1.7                   0.8                   1.9     0.8    **\<.001**    0.221    0.120    .322
  SCL: PST                      63.8                  18.9                  67.2    17.1   .**003**      3.892    1.457    6.326
  SCL: PSDI                     2.3                   0.6                   2.5     0.6    **\<.001**    0.185    0.109    .262
  TCI: novelty seeking          102.4                 16.4                  102.6   16.1   .289          1.349    −0.791   3.488
  TCI: harm avoidance           115.4                 20.0                  121.1   17.9   .**003**      4.381    1.809    6.952
  TCI: reward dependence        103.6                 15.4                  103.9   17.0   .638          −0.596   −2.710   1.518
  TCI: persistence              111.1                 21.5                  106.8   21.9   .**030**      −3.496   −6.371   −.622
  TCI: self-directedness        118.4                 21.8                  112.3   21.1   .**000**      −5.231   −8.082   −2.379
  TCI: cooperativeness          135.7                 17.3                  133.1   17.7   .**023**      −3.013   −5.311   −.715
  TCI: self-transcendence       65.5                  14.8                  65.9    15.2   .901          0.125    −1.844   2.093

Results obtained in analysis of variance (ANOVA) adjusted by age, duration of ED and subtype. *p* values include Bonferroni--Holm\'s correction. In bold: *p* \< .05; ED, eating disorders; OB, obesity; BMI, body mass index; BITE, Bulimic Investigatory Test Edinburgh; EDI, Eating Disorders Inventory; SCL, Symptom Checklist-90; GSI, Global Severity Index; PST, Positive Symptom Total; PSDI, Positive Symptom Disease Index; TCI, Temperament and Character Inventory.

Discussion
==========

The main finding was the high and increasing temporal prevalence of lifetime obesity in ED (28.8% of cases), particularly in BED/BN.

The second main finding of our study was that ED patients with lifetime obesity were characterized by later age of onset, higher ED severity and greater general psychopathology when compared with patients without lifetime obesity. This group had a poorer prognosis (Bulik, Sullivan, Joyce, Carter, & McIntosh, [@b4]; Fairburn et al., [@b12]). As reported in previous studies, people with obesity history had a stronger family history of obesity (Nuñez-Navarro et al., [@b31]; Whitaker, Jarvis, Beeken, Boniface, & Wardle, [@b39]) with increased childhood obesity (Brisbois, Farmer, & McCargar, [@b3]). This combination is associated with higher levels of eating and general psychopathology (Dingemans & van Furth, [@b11]) and more dysfunctional personality traits (namely higher harm avoidance, lower persistence, self-directedness and cooperativeness; Nasser et al., [@b30]).

The third main finding was that the threefold increase in obesity in the ED population, mainly in BED and BN, over the last 10 years, is much higher than the changing prevalence recorded in women in general population surveys (FESNAD-SEEDO, [@b15]; OECD, [@b32]). This is in agreement with the observation previously reported in other ED-related populations (McAlpine et al., [@b28]; Müller et al., [@b29]).

The results of this study should be considered within the context of the following limitations: First, the retrospective and self-report data collection procedures may limit the validity and the reliability of our findings. Second, the cross-sectional design does not allow us to determine the causality of the variables assessed. Therefore, it will be important to confirm the relevance of these results by longitudinal research that will determine the patterns of temporal association.

Research suggests that adolescents may simultaneously experience multiple weight-related problems, increasing severity over time. Therefore, clinicians treating individuals with obesity or ED should remain vigilant for the emergence of additional weight-related problems. Further, in the treatment of patients with ED and obesity, multidisciplinary approaches addressing both conditions may eventually produce superior effectiveness than those that concentrate exclusively on the problem for which the individual sought treatment.

In summary, lifetime obesity seems to become more and more prevalent among ED patients (as preceding, coexisting or consequent condition). Therefore, ED services may need to adjust their treatments to match the changing clinical profile and also when designing early or tertiary prevention strategies (Gonzalez, Penelo, Gutierrez, & Raich, [@b19]; Koskina et al., [@b26]).
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